Trade Rein Therapeutics Inc - ALRN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0436 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.8232 |
| Open | 1.8032 |
| 1-Year Change | -63.09% |
| Day's Range | 1.8032 - 1.9032 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 1.8832 | 0.0800 | 4.44% | 1.8032 | 1.9032 | 1.8032 |
| Apr 24, 2025 | 1.8232 | 0.0100 | 0.55% | 1.8132 | 1.8532 | 1.7232 |
| Apr 23, 2025 | 1.7632 | -0.0300 | -1.67% | 1.7932 | 1.7932 | 1.7632 |
| Apr 22, 2025 | 1.8732 | 0.1100 | 6.24% | 1.7632 | 1.8832 | 1.7432 |
| Apr 21, 2025 | 1.7432 | 0.1800 | 11.51% | 1.5632 | 1.7432 | 1.5432 |
| Apr 17, 2025 | 1.6332 | 0.0000 | 0.00% | 1.6332 | 1.6632 | 1.5732 |
| Apr 16, 2025 | 1.6332 | -0.0100 | -0.61% | 1.6432 | 1.7232 | 1.6032 |
| Apr 15, 2025 | 1.6432 | 0.0300 | 1.86% | 1.6132 | 1.6832 | 1.6132 |
| Apr 14, 2025 | 1.6032 | 0.0400 | 2.56% | 1.5632 | 1.6232 | 1.5632 |
| Apr 11, 2025 | 1.5932 | 0.0700 | 4.60% | 1.5232 | 1.5932 | 1.4432 |
| Apr 10, 2025 | 1.5432 | 0.1200 | 8.43% | 1.4232 | 1.5432 | 1.3832 |
| Apr 9, 2025 | 1.4332 | 0.0900 | 6.70% | 1.3432 | 1.4332 | 1.3432 |
| Apr 8, 2025 | 1.3432 | -0.2200 | -14.07% | 1.5632 | 1.5632 | 1.3432 |
| Apr 7, 2025 | 1.5132 | -0.1100 | -6.78% | 1.6232 | 1.7132 | 1.5132 |
| Apr 4, 2025 | 1.6632 | 0.0600 | 3.74% | 1.6032 | 1.7232 | 1.4932 |
| Apr 3, 2025 | 1.6532 | 0.0100 | 0.61% | 1.6432 | 1.6532 | 1.6432 |
| Apr 2, 2025 | 1.7832 | -0.0300 | -1.65% | 1.8132 | 1.8232 | 1.7132 |
| Apr 1, 2025 | 1.6732 | -0.1200 | -6.69% | 1.7932 | 1.9132 | 1.6732 |
| Mar 31, 2025 | 1.7632 | 0.0200 | 1.15% | 1.7432 | 1.8932 | 1.7332 |
| Mar 28, 2025 | 1.6832 | -0.0400 | -2.32% | 1.7232 | 1.7232 | 1.6732 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Aileron Therapeutics, Inc. Company profile
About Aileron Therapeutics Inc
Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. The Company is focused on transforming the experience of chemotherapy for cancer patients. It is developing ALRN-6924, which is their dual Mouse double minute 2 homolog (MDM2) and MDMX inhibitor to provide a single medicine to protect multiple healthy cell types throughout the body from chemotherapy while ensuring chemotherapy continues to destroy cancer cells. ALRN-6924 acts as an agent to reduce the toxic side effects of chemotherapy in the bone marrow of cancer patients without adversely impacting the anti-cancer activity of chemotherapy against p53-mutant tumors.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Aileron Therapeutics Inc revenues was not reported. Net loss increased 20% to $19.4M. Higher net loss reflects Research and development increase of 38% to $12.1M (expense), Stock-based Compensation in SGA increase of 20% to $1.3M (expense), General and administrative increase of 1% to $6.1M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.51 to -$0.22.
| Industry: | Bio Therapeutic Drugs |
285 Summer Street
Unit 101
BOSTON
MASSACHUSETTS 02210
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com